The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Percutaneous Mechanical Circulatory Support Devices Market Evolve From 2026 To 2030?
The percutaneous mechanical circulatory support devices market size has shown robust growth in recent years. Its value is anticipated to rise from $2.46 billion in 2025 to $2.7 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.7%. This expansion during the historic period can be ascribed to a climbing burden of cardiovascular disease, an increase in cardiogenic shock cases, the uptake of minimally invasive procedures, broader ICU care, and an aging population.
The percutaneous mechanical circulatory support devices market size is projected to undergo significant expansion in the upcoming years, with its value set to reach $3.87 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This growth during the forecast period is propelled by factors such as AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the expansion of cath lab procedures, the escalating demand for temporary heart support, and advanced pump technologies. Noteworthy trends anticipated in the forecast period include advancements in minimally invasive cardiac support, short-term hemodynamic assistance solutions, devices for high-risk PCI support, rapid deployment cardiac systems, and designs focused on enhanced patient safety.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp
What Major Drivers Are Influencing Demand In The Percutaneous Mechanical Circulatory Support Devices Market?
The escalating occurrence of cardiovascular diseases is anticipated to drive expansion in the percutaneous mechanical circulatory support devices market. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. This rise in CVD incidence stems from factors like an aging demographic, unhealthy lifestyle decisions, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices are employed for cardiovascular diseases to enhance cardiac function, alleviate heart strain, and aid recovery during severe heart conditions. As an illustration, the Centers for Disease Control and Prevention, a US-based public health institute, reported in October 2024 that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old, with a total of 919,032 people dying from cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the growing occurrence of cardiovascular diseases is fueling the expansion of the percutaneous mechanical circulatory support (MCS) devices market.
Which Segment Areas Are Covered In The Percutaneous Mechanical Circulatory Support Devices Market Analysis?
The percutaneous mechanical circulatory support devices market covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
What Key Developments And Trends Are Impacting The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are concentrating on developing technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device serves as a type of percutaneous mechanical circulatory support (MCS) device engineered to aid heart function by augmenting blood flow from the left ventricle to the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device company, announced the successful first-in-human use of its Aortix pump. This innovative device is designed to prevent acute kidney injury (AKI) in patients undergoing cardiac surgery. Delivered via a catheter in the descending thoracic aorta, the Aortix pump improves renal perfusion while decreasing the heart’s workload during surgery, achieving this by enhancing both renal and systemic perfusion while simultaneously reducing the strain on the heart, making it particularly advantageous for patients with compromised left ventricular function and renal impairment. Capable of delivering up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary use during procedures such as percutaneous coronary interventions (PCI).
Which Global Companies Are Actively Competing In The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.
Read the full percutaneous mechanical circulatory support devices market report here:
Which Region Shows The Strongest Potential For Future Growth In The Percutaneous Mechanical Circulatory Support Devices Market?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Percutaneous Mechanical Circulatory Support Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp
Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company
Peripheral Vascular Devices And Equipment Market Report 2026
Cardiovascular Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Cardiac Assist Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model